Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
Details for Australian Patent Application No. 2004288692 (hide)
International Classifications
Event Publications
25 May 2006 PCT application entered the National Phase
PCT publication WO2005/046589 Priority application(s): WO2005/046589
20 November 2008 Alteration of Name
The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.
17 February 2011 Application Accepted
Published as AU-B-2004288692
16 June 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004288704-Fluid verification system and method for infusions
2004288687-Implantable radiotherapy/brachytherapy radiation detecting apparatus and methods
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser